Correlation Between Day One and Briacell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Day One and Briacell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Briacell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Briacell Therapeutics Corp, you can compare the effects of market volatilities on Day One and Briacell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Briacell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Briacell Therapeutics.
Diversification Opportunities for Day One and Briacell Therapeutics
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Day and Briacell is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Briacell Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Briacell Therapeutics and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Briacell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Briacell Therapeutics has no effect on the direction of Day One i.e., Day One and Briacell Therapeutics go up and down completely randomly.
Pair Corralation between Day One and Briacell Therapeutics
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Briacell Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 3.05 times less risky than Briacell Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Briacell Therapeutics Corp is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 83.00 in Briacell Therapeutics Corp on August 30, 2024 and sell it today you would earn a total of 1.00 from holding Briacell Therapeutics Corp or generate 1.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Briacell Therapeutics Corp
Performance |
| Timeline |
| Day One Biopharmaceu |
| Briacell Therapeutics |
Day One and Briacell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Briacell Therapeutics
The main advantage of trading using opposite Day One and Briacell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Briacell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Briacell Therapeutics will offset losses from the drop in Briacell Therapeutics' long position.| Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
| Briacell Therapeutics vs. X4 Pharmaceuticals | Briacell Therapeutics vs. Terns Pharmaceuticals | Briacell Therapeutics vs. Day One Biopharmaceuticals | Briacell Therapeutics vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |